Area of research
Cancer Research · Economics and Econometrics
Research interest
Research interests include Economic and Financial Impacts of Cancer, Advanced Breast Cancer Therapies, Cancer Immunotherapy and Biomarkers, and Cancer Genomics and Diagnostics.
Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trials
Current controversies in the use of Oncotype DX in early breast cancer
Prognostic impact of tumor-infiltrating lymphocytes in HER2+ metastatic breast cancer receiving first-line treatment
The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit
206P Prognostic role of tumor-infiltrating lymphocytes (TILs) in first-line HER2-positive (HER2+) metastatic breast cancer (BC): A real-world study
WITHDRAWN: Using antibody-drug conjugates for anti-tumor immunity
Immunotherapy for breast cancer: New strategies to enhance the patient selection and overcome therapeutic resistance
Using antibody-drug conjugates for anti-tumor immunity
Prognostic impact of tumor-infiltrating lymphocytes in HER2+ metastatic breast cancer receiving first-line treatment
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
Common Sense Oncology: outcomes that matter
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
The immunogram of inflammatory breast cancer
The rise of immuno-oncology in China: a challenge to western dominance?
Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases
Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification
The Global Landscape of Treatment Standards for Breast Cancer
The ESSO core curriculum committee update on surgical oncology
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden
Examining policy cohesion for cervical cancer worldwide: analysis of WHO country reports
Evaluating triptorelin as a treatment option for breast cancer